OBJECTIVE: We evaluated the prognostic significance of CD44 isoform CD44 V6 in endometrial cancer. METHOD: Immunohistochemistry was used to determine the expression of CD44 V6 in 78 randomly selected endometrial cancer specimens. RESULTS: CD44 V6 was detected in 53% (41/78) of the tumor samples. Clinicopathological evaluation revealed an inverse correlation with CD44 V6 expression and conventional poor prognosticators such as lower segment involvement, nuclear and structural grade, myometrial invasion, serosal involvement, lymph-vascular space invasion, and adnexal metastasis. Furthermore, the CD44 V6-negative group was found to be associated have a higher recurrence rate and a shorter disease-free survival. CONCLUSION: These findings indicate that absence of CD44 V6 expression in cases of endometrial cancer might be coupled with a more aggressive course. Copyright 2001 Academic Press.
OBJECTIVE: We evaluated the prognostic significance of CD44 isoform CD44 V6 in endometrial cancer. METHOD: Immunohistochemistry was used to determine the expression of CD44 V6 in 78 randomly selected endometrial cancer specimens. RESULTS:CD44 V6 was detected in 53% (41/78) of the tumor samples. Clinicopathological evaluation revealed an inverse correlation with CD44 V6 expression and conventional poor prognosticators such as lower segment involvement, nuclear and structural grade, myometrial invasion, serosal involvement, lymph-vascular space invasion, and adnexal metastasis. Furthermore, the CD44 V6-negative group was found to be associated have a higher recurrence rate and a shorter disease-free survival. CONCLUSION: These findings indicate that absence of CD44 V6 expression in cases of endometrial cancer might be coupled with a more aggressive course. Copyright 2001 Academic Press.
Authors: Meenakshi Singh; Kathleen M Darcy; William E Brady; Rashna Clubwala; Zachary Weber; Jon V Rittenbach; Ali Akalin; Charles W Whitney; Richard Zaino; Nilsa C Ramirez; Kimberly K Leslie Journal: Gynecol Oncol Date: 2011-08-03 Impact factor: 5.482
Authors: Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak Journal: FEBS J Date: 2011-03-25 Impact factor: 5.542
Authors: D Bhattacharya; D Svechkarev; J J Souchek; T K Hill; M A Taylor; A Natarajan; A M Mohs Journal: J Mater Chem B Date: 2017-09-20 Impact factor: 6.331
Authors: Suniti Misra; Vincent C Hascall; Carla De Giovanni; Roger R Markwald; Shibnath Ghatak Journal: J Biol Chem Date: 2009-02-26 Impact factor: 5.157
Authors: Michał Wojciechowski; Tomasz Krawczyk; Janusz Śmigielski; Andrzej Malinowski Journal: Arch Gynecol Obstet Date: 2014-08-17 Impact factor: 2.344
Authors: M H Kiyohara; C Dillard; J Tsui; S R Kim; J Lu; D Sachdev; L Goodglick; M Tong; V F Torous; C Aryasomayajula; W Wang; P Najafzadeh; L K Gordon; J Braun; S McDermott; M S Wicha; M Wadehra Journal: Oncogene Date: 2017-06-12 Impact factor: 8.756